Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 5.
doi: 10.1097/IJG.0000000000002616. Online ahead of print.

Standalone Canaloplasty and Trabeculotomy Using the OMNI Surgical System in Patients with Open-Angle Glaucoma: A Systematic Review and Meta-analysis

Affiliations

Standalone Canaloplasty and Trabeculotomy Using the OMNI Surgical System in Patients with Open-Angle Glaucoma: A Systematic Review and Meta-analysis

Daniel Zhu et al. J Glaucoma. .

Abstract

Precis: This systematic review and meta-analysis found that standalone OMNI resulted in significant intraocular pressure (IOP) reduction at the 1-month, 6-month, 1-year, and 2-year time points and significantly improved topical medication burden at 1-year.

Purpose: To determine the efficacy of standalone canaloplasty and trabeculotomy using the OMNI Surgical System in open-angle glaucoma (OAG) patients.

Methods: A systematic review was performed using the PubMed, Embase, and Scopus databases for all studies using the OMNITM Surgical System for standalone canaloplasty and trabeculotomy in OAG patients with baseline intraocular pressure (IOP) >18 mmHg (PROSPERO ID: CRD420251044505). Meta-analyses were performed to calculate the IOP change following treatment at 1-month, 6-month, 1-year, and 2-year follow-ups. We also evaluated changes in topical medications and the proportion of medication-free patients at 1 year.

Results: Five studies with 290 eyes at baseline were included. At the 1-month follow-up, there was a significant mean IOP reduction of 7.40 mmHg following standalone OMNI (MD=-7.40; 95% CI: -10.61 to -4.20; P<0.0001). At the 6-month follow-up, mean IOP reduction was 7.25 mmHg (MD=-7.25; 95% CI: -9.60 to -4.89; P<0.0001). At the 1-year follow-up, mean IOP reduction was 7.49 mmHg (MD=-7.49; 95% CI: -9.47 to -5.50; P<0.0001). At 2-year follow-up, mean IOP reduction was 8.77 mmHg (MD=-8.77; 95% CI: -10.35 to -7.19; P<0.0001). Additionally, at the 1-year follow-up, mean reduction of topical medications was 0.77 (MD=-0.77; 95% CI: -1.44 to -0.09; P=0.025), and 46.2% of patients were medication-free (95% CI: 35.6%-57.2%).

Conclusions: The OMNI Surgical System is an effective standalone procedure for canaloplasty and trabeculotomy in OAG patients and led to a significant reduction in IOP at multiple timepoints and medication burden.

Keywords: MIGS; OMNI; canaloplasty; glaucoma; minimally invasive glaucoma surgeries; trabeculotomy.

PubMed Disclaimer

Similar articles

LinkOut - more resources